Shedding Light on the Risks
& Benefits of Medications
Welcome to the FDA Recalls and Warnings Update, a series dedicated to keeping you informed about the latest medication recalls, manufacturing violations, and quality concerns…
Feb 14, 2025
Tirzepatide, known by the brand names Mounjaro and Zepbound, is an injectable drug approved by the US Food and Drug Administration (FDA) for the treatment of type 2…
Feb 12, 2025
One of Ellen Smith’s favorite activities is to walk with her service dog Velma along the bay near her home in North Scituate, RI. The…
Feb 6, 2025
In 2023, one in five Americans reported experiencing symptoms of anxiety and depression, according to the Centers for Disease Control and Prevention (CDC). For those managing…
Jan 29, 2025
Semaglutide, a drug marketed under the brand names Ozempic, Rybelsus and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist primarily used in the treatment of type 2 diabetes and obesity.…
Jan 13, 2025
As the engine that turns our food into the fuel we need—and gets rid of what we don’t—our digestive tract is critical to sustaining life.…
Jan 13, 2025
Welcome to the FDA Side Effects Update. This series is designed to keep you informed about the latest safety advisories and newly documented side effects…
Jan 13, 2025
Margie Minkler started getting hot flashes in her early 40s. “It feels like a cartoon of somebody who is turning red from their toes up…
Dec 18, 2024
Each year, a select group of novel new drugs enter the U.S. market. In 2023, 55 new drugs were approved—adding to the more than 20,000 prescription drugs already in…
Dec 13, 2024
When sold in supplement form, melatonin is often marketed as a common over-the-counter sleep aid. However, individuals taking prescription Ambien (zolpidem) should consult with a physician before taking…
Dec 5, 2024
